Facebook
Twitter
Telegram
Report an ErrorOnconova Therapeutics Cash Flow 2011-2024 | ONTX
Annual Cash Flow Onconova Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
-17.9 M | -16.3 M | -19.5 M | -23.1 M | -20.8 M | -22.7 M | -23.8 M | -15.8 M | - | - | - | - | - |
Depreciation & Amortization |
16 K | 14 K | 14 K | 13 K | 14 K | 55 K | 88 K | 96 K | 150 K | 434 K | 446 K | 319 K | 316 K |
Accounts Payables |
5.62 M | 3.86 M | 2.76 M | 4.83 M | 4.27 M | 4.04 M | 6.19 M | 5.32 M | 3.42 M | 4.03 M | 3.71 M | - | - |
Accounts Receivables |
18 K | 29 K | 28 K | 37 K | 98 K | 35 K | 59 K | 31 K | 1.5 M | - | - | - | - |
Total Inventories |
- | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Cash Flow Onconova Therapeutics
| 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
-4.42 M | - | - | - | -4.54 M | - | -12.4 M | -8.51 M | -4.3 M | - | -15.2 M | -11 M | -6.65 M | - | -17.6 M | -11.8 M | -6.46 M | - | -15.5 M | -11.5 M | -6.6 M | - | -17.3 M | -10.1 M | -5.51 M | - | -19.1 M | -11.7 M | -6.06 M | - | -11.4 M | -8.59 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Depreciation & Amortization |
4 K | - | - | - | 3 K | - | 10 K | 7 K | 3 K | - | 10 K | 7 K | 3 K | - | 9 K | 5 K | 3 K | - | 11 K | 8 K | 8 K | - | 44 K | 30 K | 16 K | - | 69 K | 47 K | 23 K | - | 72 K | 48 K | 24 K | - | 125 K | 98 K | 72 K | - | 336 K | 239 K | 141 K | - | 326 K | 207 K | 98 K | - | 232 K | 157 K | - | - | - | - | - |
Accounts Payables |
6.57 M | 5.62 M | 6.15 M | 5.07 M | 4.9 M | 3.86 M | 3.76 M | 3 M | 3.12 M | 2.76 M | 4.05 M | 4.29 M | 3.99 M | 4.83 M | 4.83 M | 4.83 M | 4.83 M | 4.27 M | 4.27 M | 4.27 M | 4.27 M | 4.04 M | 4.04 M | 4.04 M | 4.04 M | 6.19 M | 6.19 M | 6.19 M | 6.19 M | 5.32 M | 5.32 M | 5.32 M | 5.32 M | 3.42 M | 3.42 M | 3.42 M | 3.42 M | 4.03 M | 4.03 M | 4.03 M | 4.03 M | 3.71 M | 3.71 M | 3.71 M | 3.71 M | 5.52 M | 5.52 M | 5.52 M | - | - | - | - | - |
Accounts Receivables |
18 K | 18 K | 18 K | 17 K | 17 K | 29 K | 28 K | 28 K | 27 K | 28 K | 29 K | 27 K | 38 K | 37 K | 37 K | 37 K | 37 K | 98 K | 98 K | 98 K | 98 K | 35 K | 35 K | 35 K | 35 K | 59 K | 59 K | 59 K | 59 K | 31 K | 31 K | 31 K | 31 K | 1.5 M | 1.5 M | 1.5 M | 1.5 M | 132 K | 132 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Inventories |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency